Mode
Text Size
Log in / Sign up
N/A N=60 Randomized Supportive Care

Telehealth Delivery (Tele-B6)

HIV Seropositivity · Bisexuality

Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcome: Primary: Acceptability Scale — 4.63; 4.68; 4.60; 4.70 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Tele-B6 (Behavioral); Delayed intervention (waitlist control) (Behavioral)
Age
Adult · 18+ yrs
Sex
Male
Sponsor
Emory University
Primary completion
Nov 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Acceptability Scale
4.63; 4.68; 4.60; 4.70; 4.65; 4.73
PRIMARY
Number of Attended Sessions
3.73; 3.0
PRIMARY
Number of Participants Reporting Adverse Events (Safety)
0; 0
SECONDARY
The Material Resources Survey
3.43; 3.19; 3.60; 2.97; 3.27; 3.44
SECONDARY
Everyday Discrimination Scale
1.59; 1.73; 1.48; 2.08; 1.85; 2.22
SECONDARY
Perception of HIV Stigma Scale
2.18; 2.61; 2.11; 2.53; 2.10; 2.51
SECONDARY
Personal Social Capital Scale
24.35; 23.27; 24.85; 22.37; 26.07; 24.05
SECONDARY
Number of Participants With Studies Depression Scale Greater Than 16
16; 16; 12; 14; 12; 12
SECONDARY
General Well-being (GWB) Survey
66.2; 60.3; 71.8; 60.6; 65.7; 63.67

Summary

The research team has developed an interventional group program for young men living with HIV and will be adapting it for telehealth delivery. The purpose of the study is to determine whether or not this program can help improve social connections and the health of young men in online delivery and evaluate its potential for implementation in a community setting. The study has three phases: (1) engaging a community advisory board to create and adapt the intervention for online delivery, (2) a randomized clinical trial of the online intervention, and (3) evaluation of the program for community implementation with our partner organization. Participants in the second phase of the study will meet with a study team member to discuss the research process and provide informed consent. The community organization employees will provide consent online prior to completion of a survey and indicate whether they consent to be contacted further for in-depth interviews.

Eligibility Criteria

Inclusion Criteria

  • Black race, inclusive of multiracial identities male gender, inclusive of transgender men
  • self-identification as gay, bisexual, or another non-heterosexual orientation, and/or any history of consensual anal or oral sex with men
  • HIV-positive serostatus
  • age 18-29 years inclusive
  • residence in the Atlanta Metropolitan Statistical Area
  • available and interested in meeting for two hours weekly over five weeks.

Exclusion Criteria

  • Age 30 years
  • Unwilling or unable to provide written informed consent
  • Enrollment in one phase of the study is an exclusion criterion for enrollment in other phases
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05829759). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search